EP0591275A1 — Use of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione in the treatment of tyrosinaemia and pharmaceutical compositions
Assigned to Syngenta Ltd · Expires 1994-04-13 · 32y expired
What this patent protects
New pharmaceutical compositions containing as active ingredient a 2-benzoyl-1,3-cyclohexanedione, inhibitor of the enzyme 4-hydroxyphenylpyruvate dioxygenase (HPPD). These compositions are of great interest for the treatment of disorders and diseases for which it is desirable to …
USPTO Abstract
New pharmaceutical compositions containing as active ingredient a 2-benzoyl-1,3-cyclohexanedione, inhibitor of the enzyme 4-hydroxyphenylpyruvate dioxygenase (HPPD). These compositions are of great interest for the treatment of disorders and diseases for which it is desirable to intervene in the metabolic sequences catalyzed by HPPD, such as the treatment of tyrosinemia type I.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.